Closing the Common Heart Defect a Great Success Using FlatStent PFO Closure System

Coherex Medical, Inc., successfully completed the first human cases of its Coherex FlatStent PFO Closure System.

Under the direction of Professor Horst Sievert, M.D. (an internationally renowned interventional cardiologist and Principal Investigator for the COHEREX -EU Study), Coherex successfully conducted procedures in Frankfurt, Germany to close the common heart defect known as a Patent Foramen Ovale (PFO). Joining Dr. Sievert in these cases were:

• Brian Whisenant, M.D., Coherex founder and chairman, and interventional cardiologist with the Utah Heart Clinic at LDS Hospital in Salt Lake City;
• Robert Sommer, M.D., director of the Adult Invasive Congenital Heart Services Center at New York-Presbyterian Hospital/Columbia University Medical Center and associate professor of clinical medicine and pediatrics at Columbia University; and
• Jonathan M. Tobis, M.D., professor of medicine and director, Interventional Cardiology at the David Geffen School of Medicine at UCLA.

These initial procedures were performed at Sankt Katharinen Hospital in Frankfurt as part of the company's COHEREX-EU Study.

Coherex expects to include data from these cases in its application for CE Mark clearance.